Eculizumab, Poor Response To

Clinical Features

Phenotypes and symptoms related to Eculizumab, Poor Response To

  • Hemoglobinuria
  • Paroxysmal nocturnal hemoglobinuria

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
No data available about the known clinical features onset.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Eculizumab, Poor Response To Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Atypical hemolytic uremic syndrome.

By Northern Molecular Genetics Service Newcastle Upon Tyne Hospitals NHS Foundation Trust (United Kingdom).

CFB, THBD, C3, C5, ADAMTS13, INF2, MMACHC, DGKE, CFH, CFI, CD46
Specificity
10 %
Genes
100 %
C5 deficiency.

By Centogene AG - the Rare Disease Company (Germany).

C5
Specificity
100 %
Genes
100 %
Complement deficiencies Panel.

By CeGaT GmbH (Germany).

CFB, THBD, SERPING1, C1QA, C1QB, C1QC, C1R, C1S, C2, C3, C4A, C4B, C5, C6, C7, C8A, C8B, C8G, C9, CD59 , (...)

View the complete list with 14 more genes
Specificity
3 %
Genes
100 %
C5.

By Fulgent Genetics Fulgent Genetics (United States).

C5
Specificity
100 %
Genes
100 %
Complement System Disorder Panel.

By Blueprint Genetics (Finland).

CFB, SPAG1, THBD, SERPING1, RSPH1, C1QA, C1QB, C1QBP, C1QC, C1S, C2, VTN, C3, C3AR1, C4BPA, C4BPB, C5, C5AR1, C6, C7 , (...)

View the complete list with 55 more genes
Specificity
2 %
Genes
100 %

You can get up to -3 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM Rare Disease Search Engine

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET; SNDC NEUROFIBROMATOSIS-NOONAN SYNDROME MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS; MMCAT FG SYNDROME 4; FGS4 LACTATE DEHYDROGENASE B DEFICIENCY; LDHBD FARBER LIPOGRANULOMATOSIS; FRBRL AGNATHIA-HOLOPROSENCEPHALY-SITUS INVERSUS SYNDROME